US states step in to regulate reprocessors of single-use devices in view of FDA "policy vacuum"
This article was originally published in Clinica
The FDA is facing renewed pressure from industry over its refusal to take regulatory action against the third party processing of single-use devices. The US Medical Device Manufacturers Association (MDMA) said last week that it is contemplating a lawsuit or legislation if the FDA refuses to act on the issue soon.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.